美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）
检索条件:" 注册申请号=ANDA075853"
符合检索条件的记录共 3 条，共 1 页，当前第 1 页 ，可点击列名称排序
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
51662-1457-1 51662-1457 HUMAN PRESCRIPTION DRUG DILTIAZEM HCI DILTIAZEM HCI INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION INTRAVENOUS 20191215 N/A ANDA ANDA075853 HF Acquisition Co LLC, DBA HealthFirst DILTIAZEM HYDROCHLORIDE 100 mg/1 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, PATENT DELIVERY SYSTEM (51662-1457-1)
51662-1457-3 51662-1457 HUMAN PRESCRIPTION DRUG DILTIAZEM HCI DILTIAZEM HCI INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION INTRAVENOUS 20221211 N/A ANDA ANDA075853 HF Acquisition Co LLC, DBA HealthFirst DILTIAZEM HYDROCHLORIDE 100 mg/1 10 POUCH in 1 CASE (51662-1457-3) / 1 VIAL, PATENT DELIVERY SYSTEM in 1 POUCH (51662-1457-2) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, PATENT DELIVERY SYSTEM
0409-4350-03 0409-4350 HUMAN PRESCRIPTION DRUG Diltiazem Hydrochloride DILTIAZEM HYDROCHLORIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION INTRAVENOUS 20050430 N/A ANDA ANDA075853 Hospira, Inc. DILTIAZEM HYDROCHLORIDE 100 mg/1 10 VIAL, PATENT DELIVERY SYSTEM in 1 TRAY (0409-4350-03) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, PATENT DELIVERY SYSTEM (0409-4350-13)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase